The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: A critical evaluation of clinical and epidemiological models of human teratology

Expert Opinion on Drug Safety

Volumn 8, Issue 3, 2009, Pages 283-303

  Czeizel, Andrew E ^a,b  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b NONE   (Hungary)

Author keywords

Birth defects; Congenital abnormalities; Evaluation criteria; Monitoring; Pregnancy outcomes; Registries; Surveillances; Teratogenic effect of drugs

Indexed keywords

ANTIMIGRAINE AGENT; DOXYCYCLINE; ERGOTAMINE; ESTROGEN; METRONIDAZOLE; MICONAZOLE; ORAL CONTRACEPTIVE AGENT; OXYTETRACYCLINE; PAROXETINE; SULFADIMIDINE; SULFAMETHOXYPYRIDAZINE; SULFAMETOXYDIAZINE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; VALPROIC ACID;

ALCOHOL CONSUMPTION; BIRTH WEIGHT; CASE CONTROL STUDY; CHRONOPHARMACOLOGY; CONFOUNDING VARIABLE; CONGENITAL MALFORMATION; DISEASE REGISTRY; DRUG ABSORPTION; DRUG INDICATION; DRUG METABOLISM; DRUG TRANSPORT; FETOTOXICITY; HEALTH SURVEY; HUMAN; HUNGARY; LIMB MALFORMATION; POLYPHARMACY; POSTMARKETING SURVEILLANCE; PREDICTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRENATAL DRUG EXPOSURE; REVIEW; RISK ASSESSMENT; SELF POISONING; SMOKING; TERATOGENESIS; WATER POLLUTION;

ABNORMALITIES, DRUG-INDUCED; CASE-CONTROL STUDIES; FEMALE; HUMANS; HUNGARY; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGISTRIES; TERATOGENS;

EID: 67649371479     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740330902916459     Document Type: Review

References (100)

1. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 7th ed. Lippincott Williams and Wilkins: Philadelphia, 2005
2. Friedman JM, Polifka JE. The Effects of Drugs on the Fetus and Nursing Infant. Johns Hopkins Univ Press: Baltimore, 2000
3. Shepard TH, Lemire RJ. Catalog of Teratogenic Agents, 11th ed. Johns Hopkins Univ Press: Baltimore, 2004
4. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group: Littleton, MA, 1977
5. Kallen B. Epidemiology of Human Reproduction. CRC Press: Boca Raton, Florida, 1988
6. Creasy RK, Resnik R, Iams JD, editors. Maternal-Fetal Medicine. Principles and Practice. 5th ed. Saunders: Philadelphia, 2004
7. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998;338:1128-1132 (Pubitemid 28227484)
8. Bauer CR, Shankaran S, Bada HS, et al. The maternal lifestyle study: drug exposure during pregnancy and short-term maternal outcome. Am J Obstet Gynecol 2002;157:1236-1240 (Pubitemid 34234162)
9. Bánhidy F, Lowry RB, Czeizel AE. Risk and benefit of drug use during pregnancy. Int J Med Sci 2005;2:100-106 (Pubitemid 41074234)
10. Czeizel AE. First 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997;55:299-305 (Pubitemid 27389919)
11. Czeizel AE, Tusnady G. Aetiological Studies of Isolated Common Congenital Abnormalities in Hungary. Akadémiai Kiadó, Budapest, 1984
12. Czeizel AE. Epidemiological studies of congenital abnormalities in Hungary. In Kalter H, editor. Issues and Reviews in Teratology 1993;6:85-124
13. Czeizel AE, Intody ZS, Modell B. What proportion of congenital abnormalities can be prevented? Brit Med J 1993;306:499-503
14. Czeizel AE, Pazonyi I. Increase of upper-limb-reduction deformities in Hungary. Lancet 1976;i:701
15. Czeizel AE, Keller S, Bod M. An aetiological evaluation of increased occurrence of congenital limb reduction abnormalities in Hungary, 1975-1978. Int J Epidemiol 1983;12:442-449 (Pubitemid 14221499)
16. Czeizel AE, Elek CS, Gundy S, et al. Environmental trichlorfon and cluster of congenital abnormalities. Lancet 1993;341:539-542 (Pubitemid 23066098)
17. Parry JM, Al-Obaidly M, Al-Walhaib M, et al. Spontaneous, induced aneuploidy, consideration which may influence chromosome male segregation. Mutat Res 2002;504:119-129 (Pubitemid 34775105)
18. Doherty AT, Ellard EM, Parry EM, Parry JM. A study of the aneugenic activity of trichorfon detected by centromere-specific probes in human lymphoblastoid cell lines. Mutat Res 1996;372:221-231 (Pubitemid 27039401)
19. Yin FY, Cukurcam S, Betzendahl I, et al. Trichlorfon exposure, spindle aberrations and non-disjunction in mammalian oocytes. Chromosome 1998;107:514-522 (Pubitemid 29057546)
20. Sun FY, Schmid TE, Schmid E, et al. Trichlorfon induces spindle disturbances in V79 cells and aneuploidy in male mouse germ cells. Mutagenesis 2000;15:17-24 (Pubitemid 30071756)
21. Cukurcam S, Sun F, Betzendahl I, et al. Trichlorfon predisposes to aneuploidy and interfers with spindle formation in in vitro maturing mouse oocyte. Mutat Res 2004;564:165-178 (Pubitemid 39422777)
22. Czeizel AE, Rockenbauer M, Siffel CS, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 2001;63:176-185 (Pubitemid 32417246)
23. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 2003;12:409-416 (Pubitemid 36903378)
24. Czeizel AE, Vargha P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004;191:790-794 (Pubitemid 39298111)
25. Bánhidy F, Ács N, Puhó E, Czeizel AE. Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth. Brit J Pharmacol 2007;1111:2125-2132 (Pubitemid 47404297)
26. Czeizel AE, Ács N, Bánhidy F, Vogt G. Possible association between maternal diseases and congenital abnormalities. (Invited review). Birth Defects New Research, NOVA Science Publisher, New York, 2006. p. 55-70
27. Czeizel AE. Self-poisoning as a model for the study of mutagenicity and teratogenicity of chemicals on human beings. In Ramel C, Lambert B, Magnussion J, editors. Genetic Toxicology of Environmental Chemicals. Part B: Genetic Effects and Applied Mutagenesis. Alan R. Liss, New York 1986. p. 237-244
28. Skegg K. Self-harm. Lancet 2005;366:1471-1483
29. Czeizel AE. The Budapest Registry of Self-poisoned Patients. Mutat Res312:157-163 (Pubitemid 24101748)
30. Czeizel AE, Gidai J, Petik D. et al. Self-poisoning during pregnancy as a model for teratogenic estimation of drugs. Toxic Indust Health 2008;24:11-28
31. Gidai J, Ács N, Bánhidy F, Czeizel AE. No association found between use of very large doses of diazepam by 112 pregnant women for a suicide attempt and congenital abnormalities in their offspring. Toxic Industr Health 2008;24:29-39
32. Gidai J, Ács N, Bánhidy F, Czeizel AE. A study of the teratogenic and fetotoxic effects of large doses of chlordiazepoxide used for self-poisoning by 35 pregnant women. Toxic Industr Health 2008;24:41-51
33. Gidai J, Ács N, Bánhidy F, Czeizel AE. An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy. Toxic Industr Health 2008;24:53-60
34. Gidai J, Ács N, Bánhidy F, Czeizel AE. A study of the effects of large doses of medazepam used for self-poisoning in 10 pregnant women on fetal development. Toxic Industr Health 2008;24:61-68
35. Petik D, Ács N, Bánhidy F, Czeizel AE. A study of the effects of large doses of glutethimide that were used for self-poisoning during pregnancy on human fetuses. Toxic Industr Health 2008;24:69-78
36. Petik G, Timmermann G, Czeizel AE, et al. A study of the teratogenic and fetotoxic effects of large doses of amobarbital used for a suicide attempt by 14 pregnant women. Toxic Industr Health 2008;24:79-85
37. Petik D, Ács N, Bánhidy F, Czeizel AE. A study of the potential teratogenic effects of large doses of promethazine for a suicide attempt by 32 pregnant women. Toxic Industr Health 2008;24:87-96
38. Timmermann G, Ács N, Bánhidy F, Czeizel AE. A study of teratogenic and fetotoxic effects of large doses of meprobamate used for a suicide attempt by 41 pregnant women. Toxic Industr Health 2008;24:97-107
39. Timmermann G, Czeizel AE, Bánhidy F, Ács N. A study of teratogenic and fetotoxic effects of large doses of barbital, hexobarbital and butobarbital used for suicide attempt by pregnant women. Toxic Industr Health 2008;24:109-119
40. Timmermann G, Ács N, Bánhidy F, Czeizel AE. A study of the potential teratogenic effects of large doses of drugs rarely used for a suicide attempt during pregnancy. Toxic Industr Health 2008;24:121-131
41. Kallen BAJ, Olansson O. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxic 2003;17:255-261 (Pubitemid 36626946)
42. Hernandez-Diaz S, Werler MM, Walker AM, Mitchel AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Eng J Med 2000;343:1608-1914 (Pubitemid 32162984)
43. Czeizel AE, Puho B. A possible association between congenital abnormalities and the use of different sulfonamides during pregnancy. Cong Anom (Kyoto) 2004;44:79-86
44. Aselton P, Jick H, Milunsky A, et al. First-trimester drug use and congenital disorders. Obstet Gynec 1985;65:451-455 (Pubitemid 15099137)
45. Rendle-Short TL. Tetracycline in teeth and bone. Lancet 1962;1:1188
46. Cohlan SQ. Tetracycline staining of teeth. Teratology 1977;15:127-130 (Pubitemid 8038357)
47. Czeizel AE, Rockenbauer M. A population-based case-control teratologic study of oral oxytetracyclines treatment during pregnancy. Eur J Obstet Gynec Reprod Biol 2000;88:27-33 (Pubitemid 30009367)
48. Czeizel AE, Rockenbauer M. Teratogenic study of doxycyline. Obstet Gynecol 1997;89:524-528
49. Czeizel AE, Rockenbauer M. A population-based case-control teratologic study of oral metronidazole treatment during pregnancy. Brit J Obstet Gynaec 1998;105:322-327 (Pubitemid 28123583)
50. Kazy Z, Puho E, Czeizel AE. Teratogenic potential of vaginal metronidazole treatment during pregnancy. Eur J Obstet Gynec Reprod Biol 2005;123:174-178 (Pubitemid 41728361)
51. Yoon PW, Rasmussen SA, Lynberg MS, et al. The National Birth Defects Prevention Study. Public Health Rep 2001;116 Suppl 1:32-40
52. Rockenbauer M, Olsen J, Czeizel AE, et al. Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology 2001;12:401-406
53. Métneki J, Sándor J, Czeizel AE. Increasing total prevalence rate of cases with Down syndrome in Hungary. Int J Epid 2005;20:525-535 (Pubitemid 40933930)
54. Nishimura H, Yamamura H. Comparison between man and some other mammals of normal and abnormal developmental processes. In Nishimura H, Miller JR, editors. Method of Teratological Studies in Experimental Animals and Man. Igaku Shoin, Tokyo 1969. p. 223-240
55. Czeizel AE. The first trimester concept is outdated. Cong Anom (Kyoto) 2001;41:204 (Pubitemid 34333042)
56. Czeizel AE, Puho HE, Ács N, Bánhidy F. The use of specified critical periods of different congenital abnormalities instead of the first trimester concept. Birth Defects Res (Part A) 2008;82:139-146
57. Czeizel AE. Specified critical period of different congenital abnormalities: A new approach for human teratology. Cong Anom (Kyoto) 2008;48:103-109
58. Ács N, Bánhidy F, Puhó E, Czeizel AE. Maternal severe migraine and risk of limb deficiencies. Birth Defects Res (Part A) 2006;76:592-601 (Pubitemid 44465320)
59. Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant agents. N Engl J Med 2001;344:1132-1135
60. Czeizel AE, Rácz J. Evaluation of drug intake during pregnancy in the Hungarian Case-Control Surveillance of Congenital Abnormalities. Teratology 1990;42:505-512 (Pubitemid 20383739)
61. Czeizel AE, Kazy Z, Puho B. A population-based case-control teratologic study of topical miconazole. Cong Anom (Kyoto) 2004;44:41-45
62. Kazy Z. Puho E, Czeizel AE. The possible association between the combination of vaginal metronidazole and miconazole treatment and poly/syndactyly. Population-based case-control teratologic study. Reprod Toxicol 2005;2:89-94
63. Tiboni GM, Marotta F, Castigliego A. Teratogenic effects in mouse fetuses subjected to the concurrent in utero exposure to miconazole and metrodinazole. Reprod Toxic 2008;26:254-261
64. Czeizel AE, Petik D, Puhó E. Smoking and alcohol drinking during pregnancy: the validity of retrospective maternal self-reported information. Centr Eur J Publ Health 2004;12:179-183 (Pubitemid 40070014)
65. Gönczi L. Czeizel AE. Integrating smoking cessation into periconceptional care. Tobacco Control 1996;5:160
66. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835 (Pubitemid 23003073)
67. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Brit Med J 1993;306:1645-1648 (Pubitemid 23168393)
68. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179-183 (Pubitemid 26090229)
69. Czeizel AE, Dobó M, Vargha P. Hungarian cohort controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res (Part A) 2004;70:853-861 (Pubitemid 39602196)
70. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet Part C 2004;125C:12-21 (Pubitemid 38140298)
71. Czeizel AE, Telegdi L, Tusnády G. Multiple Congenital Abnormalities. Akadémiai Kiadó, Budapest, 1988
72. FDA. Fetal Risk Summary. Federal Register 1980;44:37434-37467
73. FASS (Swedish System of Approved Drugs). Classification of medical products for use during pregnancy and lactation: The Swedish System. Drug Information LTD. Stockholm, 1993
74. Australian Drug Evaluation Committee. Medicines in Pregnancy: an Australian Categorization of Risk. Canberra, Australia: AGPS, 1992
75. Shaffer JP. Multiple hypothesis testing. Ann Rev Psych 1995;46:561-584
76. Perneger TV. What's wrong with Bonferroni adjustments. Brit Med J 1998;316:1236-1238 (Pubitemid 28171344)
77. Bate A, Linquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf 2002;25:393-397 (Pubitemid 34729137)
78. Meyboom RHB, Egberts ACG, Edwards IR, et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997;16:355-365 (Pubitemid 27326043)
79. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of ampicilin treatment during pregnancy. Am J Obstet Gynecol 2001;185:140-147 (Pubitemid 32681808)
80. Olsen J, Melbye M, Olsen SF, et al. The Danish National Birth Cohort: its background, structure and aim. Scand J Publ Health 2001;29:300-307 (Pubitemid 33731020)
81. Kjaer D, Horvath-puho E, Christensen J, et al. Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study. Pharmacoepid Drug Saf 2007;16:181-188 (Pubitemid 46291170)
82. Olsen J, Czeizel AE, Sorensen TH, et al. How do we best detect toxic effects of drugs taken during pregnancy? Drug Saf 2002;25:21-32
83. Honein MA, Paulozzi LJ, Cragan JD, Correa A. Evaluation of selected characteristics of pregnancy drug registries. Teratology 1999;60:356-364
84. Hardy JR, Holford TR, Hall GC, Bracken MB. Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database. Pharmacoepid Drug Saf 2004;13:749-759 (Pubitemid 39496896)
85. Wyszynski DF, Nambisan M, Surve T, et al. Antiepileptic Drug Pregnancy Registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005;64:961-965
86. Arpino C, Brescianini S, Robert E, et al. Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 2000;41:1436-1443 (Pubitemid 30813216)
87. Clementi M, Di Gianantonio E, Ornoy A. Teratology Information Service in Europe and their contribution to the prevention of congenital anomalies. Community Genet 2002;5:8-12 (Pubitemid 35316795)
88. Cnattingius S, Ericson A, Gunnarskog J, et al. A quality study of a medical birth registry. Scand J Soc Med 1990;18:143-148 (Pubitemid 20183321)
89. Kallen B, Tandberg A. Lithium and pregnancy. A cohort study on manic-depressive woman. Acta Psychiatr Scand 1983;68:134-139
90. International Center for Birth Defects of the International Clearinghouse for Birth Defects Monitoring Systems in collaboration with the Human Genetics Programme of the World Health Organization. World Atlas of the Birth Defects. 2nd ed. WHO, Geneva, 2003
91. EUROCAT. Report 8: Surveillance of Congenital Anomalies in Europe 1980-1999. University Ulster, 2002
92. The Uppsala Monitoring Centre (Online). Available from URL: http://www.who.umc.org/
93. Vallance P. Drugs and the fetus. Brit Med J 1996;312:1053-1054 (Pubitemid 26125129)
94. Czeizel AE. Analysis of medical indications for induced abortion (Hungarian with English abstract). Orvosi Hetilap 1983;124:1297-1302
95. Ács N, Bánhidy F, Horváth-Puhó E, Czeizel AE. Maternal panic disorder and congenital abnormalities - a population-based case-control study. Birth Defects Res (Part A) 2006;76:253-261
96. Ács N, Bánhidy F, Puhó E, Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res (Part A) 2005;73:989-996 (Pubitemid 43069197)
97. Vogt G, Puho E, Czeizel AE. Population-based case-control study of isolated congenital cataract. Birth Defects Res Part A 2005;73:997-1005 (Pubitemid 43069198)
98. Czeizel AE, Ács N, Bánhidy F, et al. Primary prevention of congenital abnormalities due to high fever related maternal diseases by antifever therapy and folic acid supplementation. Current Woman's Health Review 2007;3:1-12 (Pubitemid 47335358)
99. Czeizel AE, Métneki J. Evaluation of counselling for pregnant women exposed to potentially hazardous environmental factors. Acta Paediat Hung 1985;26:178-186 (Pubitemid 16207790)
100. Kjaer D, Horvath-Puho E, Christensen J, et al. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. Bit J Obstet Gynaec 2008;115:98-103 (Pubitemid 350209612)